Olanzapine induced "typical" neuroleptic malignant syndrome.
Goveas
Joseph S
JS
Hermida
Adriana
A
D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D004298:Dopamine / Q000502:physiology; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000503:physiopathology*; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D011569:Psychiatric Status Rating Scales
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine; D004298:Dopamine